Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-Operative Radiotherapy After Breast Conserving Therapy in the Treatment of in Situ and Early Stage Breast Cancer

NCT02266602 is registered in ClinicalTrials.gov with Benaroya Research Institute as lead sponsor.

NCT NCT02266602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02266602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-Operative Radiotherapy After Breast Conserving Therapy in the Treatment of in Situ and Early Stage Breast Cancer
Lead sponsor
Benaroya Research Institute
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2012
Completion date
July 31, 2018
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer